Sufentanil citrate - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for sufentanil citrate and what is the scope of patent protection?

Sufentanil citrate is the generic ingredient in three branded drugs marketed by Rising, Hikma, Hospira, Watson Labs, and Vertical Pharms, and is included in five NDAs. There are twenty-one patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sufentanil citrate has one hundred and five patent family members in twenty countries.

There are five drug master file entries for sufentanil citrate. Three suppliers are listed for this compound.

Summary for sufentanil citrate

International Patents:	105
US Patents:	21
Tradenames:	3
Applicants:	5
NDAs:	5
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	31
Clinical Trials:	7
Patent Applications:	1,102
What excipients (inactive ingredients) are in sufentanil citrate?	sufentanil citrate excipients list
DailyMed Link:	sufentanil citrate at DailyMed

Recent Clinical Trials for sufentanil citrate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Brugmann University Hospital	Phase 3
Jiangang Song	N/A
West China Hospital	Phase 4

See all sufentanil citrate clinical trials

Pharmacology for sufentanil citrate

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

Medical Subject Heading (MeSH) Categories for sufentanil citrate

Adjuvants, Anesthesia
Analgesics, Opioid
Anesthetics, Intravenous
Narcotics

Anatomical Therapeutic Chemical (ATC) Classes for sufentanil citrate

N01AH	Opioid anesthetics
N01A	ANESTHETICS, GENERAL
N01	ANESTHETICS
N	Nervous system

US Patents and Regulatory Information for sufentanil citrate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	8,226,978	⤷ Subscribe	Y			⤷ Subscribe
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	8,865,743	⤷ Subscribe				⤷ Subscribe
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	8,202,535	⤷ Subscribe				⤷ Subscribe
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	9,320,710	⤷ Subscribe				⤷ Subscribe
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	8,865,211	⤷ Subscribe				⤷ Subscribe
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET;SUBLINGUAL	209128-001	Nov 2, 2018		RX	Yes	Yes	8,778,393	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for sufentanil citrate

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Rising	SUFENTA PRESERVATIVE FREE	sufentanil citrate	INJECTABLE;INJECTION	019050-001	May 4, 1984	3,998,834	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for sufentanil citrate

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Austria	E474564		⤷ Subscribe
Canada	2673856	FORMES DOSIFIEES DE PETIT VOLUME DE MEDICAMENT CONTENANT DU SUFENTANIL S'ADMINISTRANT PAR VOIE TRANS-MUQUEUSE ORALE POUR LE TRAITEMENT DE LA DOULEUR (SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN)	⤷ Subscribe
Singapore	171786	SUFENTANIL SOLID DOSAGE FORMS COMPRISING OXYGEN SCAVENGERS AND METHODS OF USING THE SAME	⤷ Subscribe
Canada	2673837	DISPOSITIFS DE STOCKAGE ET DE DISTRIBUTION POUR L'ADMINISTRATION DE FORMES DOSIFIEES TRANS-MUQUEUSES ORALES (STORAGE AND DISPENSING DEVICES FOR ADMINISTRATION OF ORAL TRANSMUCOSAL DOSAGE FORMS)	⤷ Subscribe
European Patent Office	3730120	DISPOSITIFS DE STOCKAGE ET DE DISTRIBUTION DE MÉDICAMENTS ET SYSTÈMES LES COMPRENANT (DRUG STORAGE AND DISPENSING DEVICES AND SYSTEMS COMPRISING THE SAME)	⤷ Subscribe
Canada	2636119	FORMULATIONS DE MEDICAMENTS BIOADHESIFS POUR ADMINISTRATION PAR VOIE TRANSMUCOSALE ORALE (BIOADHESIVE DRUG FORMULATIONS FOR ORAL TRANSMUCOSAL DELIVERY)	⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for sufentanil citrate

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2114383	SPC/GB16/004	United Kingdom	⤷ Subscribe	PRODUCT NAME: SUFENTANIL; REGISTERED: UK EU/1/15/1042 20150922
2114383	16C0010	France	⤷ Subscribe	PRODUCT NAME: SUFENTANIL; REGISTRATION NO/DATE: EU/1/15/1042 20150918
2114383	CA 2016 00007	Denmark	⤷ Subscribe	PRODUCT NAME: SUFENTANIL, HERUNDER SUFENTANIL SOM CITRAT; REG. NO/DATE: EU/1/15/1042/001-006 20150922
2114383	CR 2016 00007	Denmark	⤷ Subscribe	PRODUCT NAME: SUFENTANIL; REG. NO/DATE: EU/1/15/1042/001-006 20150922
2114383	300797	Netherlands	⤷ Subscribe	PRODUCT NAME: SUFENTANIL, DESGEWENST IN DE VORM VAN SUFENTANILCITRAAT; REGISTRATION NO/DATE: EU/1/15/1042 20150922
2114383	122016000023	Germany	⤷ Subscribe	PRODUCT NAME: SUFENTANIL, WAHLWEISE IN FORM VON SUFENTANILCITRAT; REGISTRATION NO/DATE: EU/1/15/1042 20150918
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.